SV Life Sciences Advisers notes that Entellus Medical successfully listed on NASDAQ on 29 January 2015
The business wire press release is below
Nasdaq Welcomes Entellus Medical, Inc. (Nasdaq: ENTL) to The Nasdaq Stock Market
NEW YORK, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) announced that trading of Entellus Medical, Inc. (Nasdaq:ENTL), a medical technology company, commenced on The Nasdaq Stock Market on January 29, 2015.
Entellus Medical is a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room. The company is based in Plymouth, Minnesota and currently markets its products in the U.S. and Canada.
"Entellus Medical is dedicated to providing new innovative treatment for patients who need sinus relief," said Nelson Griggs, Executive Vice President, Listing Services, Nasdaq. "We are proud to welcome Entellus Medical to The Nasdaq Stock Market family and we look forward to supporting its growth and success in the future."
By listing with Nasdaq, Entellus Medical joins some of the world's largest and most revolutionary healthcare companies. Nasdaq is the exchange of choice to 77 percent of healthcare companies listed in the U.S. Markets.